pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
raps·1d ago·1 min read
save

WHO publishes first interim list of 12 medical device regulators eligible for WHO-listed authority status

Jul 28, 2026·read at raps ↗RegulatoryNeutral

The World Health Organization has released its first interim list of medical device regulators that can attain WHO-listed authority status.

The list names 12 regulators from different regions that passed an evaluation and will hold transitional listed status while they work toward full WHO-listed authority designation.

The initiative aims to harmonize device oversight worldwide and could influence how manufacturers navigate regulatory pathways for market entry.

source

This writeup was produced by pharmadog from original reporting by raps.

Original headline: “WHO announces first global list of medical device regulators eligible for listed authority standing”

read at raps ↗
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 1d agoIndustry seeks clarity, flexibility, harmonization in guidance for QSP approach for clinical trialsraps
  • 1d agoRecon: FDA says Replimune's pivotal melanoma study failed to show benefit; FDA guidance on peptides could affect development of ...raps
  • 2d agoRecon: WHO releases first interim list of medical device authorities; AstraZeneca using AI to hedge late-stage risksraps
  • 2d agoResearchers find similar drug development to reimbursement timelines for major marketsraps
  • 2d agoEMA says it takes ultimate responsibility for protecting online meeting registration, survey informationraps